Blog Archives
A meta-analysis of side effects associated with innovative treatments for SMA
Chinese researchers have gone through the data published by the American FDA with great care concerning the clinical and biological safety of three drugs commonly used in the treatment of proximal spinal muscular atrophy linked to the SMN1 gene (SMA): these researchers used a Venn-type comparative method based on data from the FDA’s pharmacovigilance system, … [Read more]
The Institute is recruiting a Research Assistant
A 1-year position of research assistant (corresponding to Ingénieur d’étude) is available at the Center of Research in Myology (UMRS 974 Inserm and Sorbonne Université, Institute of Myology, Paris, France). The position is in the team ‘Muscle cell organization and therapy of dominant centronuclear myopathy’ headed by Marc Bitoun. The candidate will be involved in … [Read more]
Recurrent compartment syndrome indicative of a genetically determined neuromuscular disease
Compartment syndrome is usually traumatic in origin, leading to muscle tissue damage with secondary necrosis, linked to hyperpressure and the resulting oedema. English and Dutch clinicians report the observations of three patients in whom the final diagnosis of genetic myopathy was made in this context: in one case, it was a myopathy with mutations in … [Read more]
Combination of ribitol and gene therapy shows synergistic effects in LGMD R9 mouse models
American researchers have sought to combine two therapeutic approaches in mouse models of FKRP-related limb-girdle muscular dystrophy type R9 (LGMD R9): oral supplementation with 5% ribitol at five weeks of age, followed four weeks later by administration of a dose of 1e13 vg/kg (low) or 5e13 vg/kg (high) of gene therapy (AAV9-FKRP). Compared with mice … [Read more]
ERN EURO-NMD webinar, 18 January : Prof. Antonio Toscano (Italy)
Rhabdomyolysis 18 January 2024 – 4pm Paris time Prof. Antonio Toscano (University of Messina, Italy) > + infos Organised by EURO-NMD in collaboration with ERN-RND.
A pilot project to detect and manage respiratory problems in pregnant women with neuromuscular disorders
The IT-NEUMA-Preg study was conducted in seven Italian hospitals between 2015 and 2022. Of the 94 pregnant women included : 24 were found to be at risk of developing respiratory disorders likely to have an impact on the pregnancy in progress or in the postnatal period, these women were able to benefit from prevention of … [Read more]
A stem cell model to assess the passage of the blood-brain barrier
British researchers have developed induced pluripotent stem cell (iPSC) lines to test the permeability of the blood-brain barrier to two therapeutic agents used in several neuromuscular diseases, including spinal muscular atrophy (SMA): three iPSC lines obtained were differentiated into endothelial cells involved in brain microvascularisation, a permeability index (endothelial electrical resistance or TEER) was defined, … [Read more]
Respiratory function in two CMDs is better understood
A natural history study carried out over one and a half years in 11 people with SELENON-related congenital muscular dystrophy (CMD) and 26 with LAMA2 revealed respiratory impairment in both diseases. Respiratory function is more impaired in SELENON-related CMD than in LAMA2-related CMD, with more frequent mechanical ventilation and more severe diaphragm dysfunction. Spirometry and … [Read more]
2024, a gesture for the muscle, for everyone’s health
Dear patients and their families, Dear donors, Dear partners, All the teams and collaborators of the Institute of Myology send you their best wishes for happiness and success and wish you excellent health. May this new, exciting and Olympic year see new scientific and therapeutic advances take shape, and enable us to carry out the … [Read more]
The favourable results of topical application of sodium thiosulphate in dermatomyositis
The CATSS-O retrospective study, for Calcifications Treated by Sodium Thiosulphate – Observational, included data acquired between 2014 and 2020 from 35 patients, including 28 with dermatomyositis or scleromyositis with ectopic calcifications that were often multiple (calcinosis). After six months of daily applications of a sodium thiosulphate-based ointment (25%) prepared by the Limoges University Hospital pharmacy, … [Read more]
